Endoscopic Treatment for Early Foregut Neuroendocrine Tumors.
- Author:
Moo In PARK
1
Author Information
1. Department of Internal Medicine, Kosin University College of Medicine, Busan, Korea. mipark@ns.kosinmed.or.kr
- Publication Type:Review
- Keywords:
Stomach;
Duodenum;
Neuroendocrine tumors;
Endoscopic treatment
- MeSH:
Duodenum;
Endoscopy;
Esophagus;
Incidence;
Lymph Nodes;
Mass Screening;
Neoplasm Metastasis;
Neuroendocrine Tumors;
Pancreas;
Stomach
- From:Clinical Endoscopy
2013;46(5):450-455
- CountryRepublic of Korea
- Language:English
-
Abstract:
Foregut neuroendocrine tumors (NETs) include those arising in the esophagus, stomach, pancreas, and duodenum and seem to have a broad range of clinical behavior from benign to metastatic. Several factors including the advent of screening endoscopy may be related to increased incidence of gastrointestinal NETs; thus, many foregut NETs are diagnosed at an early stage. Early foregut NETs, such as those of the stomach and duodenum, can be managed with endoscopic treatment because of a low frequency of lymph node and distant metastases. However, controversy continues concerning the optimal management of early foregut NETs due to a lack of controlled prospective studies. Several issues such as indications, technical issues, and outcomes of endoscopic treatment for early foregut NETs are reviewed based on some published studies.
